Additional Chromosome Structural Aberrations Are Associated with Poorer Clinical Outcomes in Multiple Myeloma Patients with Hyperdiploidy

被引：0
作者：
Carballo-Zarate, Adrian
Medeiros, L. Jeffrey
Hao, Suyang
Orlowski, Robert
Lin, Pei
Lu Xinyan
机构：
[1] UT MD Anderson Canc Ctr, Houston, TX USA
[2] Houston Methodist Hosp, Houston, TX USA
来源：
MODERN PATHOLOGY | 2016年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1341
引用
收藏
页码：338A / 338A
页数：1
相关论文
共 50 条
  • [41] Detection of chromosome aberrations in CLL and multiple myeloma using FISH probe panels.
    Ahsan, S
    Wiktor, A
    Van Dyke, D
    AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 71 (04) : 222 - 222
  • [42] IgH gene rearrangements are strongly associated with hyperdiploidy variant multiple myeloma in Korea:: A contradiction to the pathogenetic pathway of IgH tranlocations in non hyperdiploidy variant.
    Moon, HW
    Kim, TY
    Kang, SH
    Chi, HS
    Seo, EZ
    Park, CJ
    Chun, HG
    Kim, HC
    Yoon, SS
    Parks, S
    Kim, BK
    Cho, HI
    Lee, DS
    BLOOD, 2005, 106 (11) : 353B - 353B
  • [43] RELATIONSHIP BETWEEN CHROMOSOMAL ABERRATIONS AND CLINICAL OR LABORATORY VARIABLES IN MULTIPLE MYELOMA
    Wawrzyniak, E.
    Niezgodka, N.
    Siemieniuk-Rys, M.
    Blonski, J.
    Urbanska-Rys, H.
    Zych, O.
    Lakoma-Rakowska, A.
    Robak, T.
    HAEMATOLOGICA, 2014, 99 : 378 - 379
  • [44] Clinical Outcomes of Multiple Myeloma Patients Treated with Direct Oral Anticoagulants for Immunomodulatory Drug Associated Venous Thromboembolism
    Crowther, Zachary
    Doyle, Jamie
    Taylor, Stanford
    Ali, Nadia
    BLOOD, 2019, 134
  • [45] Molecular and Clinical Characteristics of 26 Cases with Structural Y Chromosome Aberrations
    Kim, J. -W.
    Park, S. -Y.
    Ryu, H. -M.
    Lee, D. -E.
    Lee, B. -Y.
    Kim, S. -Y.
    Park, Y. -S.
    Lee, H. -S.
    Seo, J. -T.
    CYTOGENETIC AND GENOME RESEARCH, 2012, 136 (04) : 270 - 277
  • [46] Clinical and Immunohistochemical Features Associated with a Response to Bortezomib in Patients with Multiple Myeloma
    Dawson, Mark A.
    Opat, Stephen S.
    Taouk, Yamna
    Donovan, Mark
    Zammit, Michele
    Monaghan, Katherine
    Horvath, Noemi
    Roberts, Andrew W.
    Prince, H. Miles
    Hertzberg, Mark
    McLean, Catriona A.
    Spencer, Andrew
    CLINICAL CANCER RESEARCH, 2009, 15 (02) : 714 - 722
  • [47] Persistency with zoledronic acid is associated with clinical benefit in patients with multiple myeloma
    Henk, Henry J.
    Teitelbaum, April
    Perez, Jose Ricardo
    Kaura, Satyin
    AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (05) : 490 - 495
  • [48] Obesity is associated with clinical characteristics in African American multiple myeloma patients
    Hwang, Amie E.
    Ailwadhi, Sikander
    Huff, Carol Ann
    Bernal-Mizrachi, Leon
    Haiman, Christopher A.
    Peters, Edward
    Singhal, Seema
    Pawlish, Karen
    Bock, Cathryn
    Zimmerman, Todd
    Van Den Berg, David J.
    Conti, David V.
    Birmann, Brenda B.
    Mehta, Jayesh
    Graff, John J.
    Stram, Daniel O.
    Brown, Niquelle
    Yu, Yang
    Azadian, Moosa
    Kolonel, Laurence
    Henderson, Brian E.
    Mohrbacher, Ann
    Colditz, Graham
    Chiu, Brian-C
    Tomasson, Michael
    Zonder, Jeffrey
    Orlowski, Robert Z.
    Lonial, Sagar
    Cozen, Wendy
    CANCER RESEARCH, 2014, 74 (19)
  • [49] NUMERICAL AND STRUCTURAL CHROMOSOME-ABERRATIONS IN CULTURED LYMPHOCYTES AND CUTANEOUS FIBROBLASTS OF PATIENTS WITH MULTIPLE ADENOMAS OF THE COLORECTUM
    GARDNER, EJ
    ROGERS, SW
    WOODWARD, S
    CANCER, 1982, 49 (07) : 1413 - 1419
  • [50] Clinical Factors Associated to VTE in Multiple Myeloma Patients Treated with Daratumumab
    Subramanian, Naveen G.
    Aung, Fleur M.
    Patel, Krina
    Lee, Hans C.
    Jin, Shida
    Young, Elliana
    Hernandez, Cristhiam Mauricio Rojas
    BLOOD, 2022, 140 : 5177 - 5179
12345